UK markets open in 4 hours 52 minutes

MGC Pharmaceuticals Limited (MXC.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
20.500.00 (0.00%)
At close: 04:35PM GMT
Currency in GBp

Valuation measures4

Market cap (intra-day) 9.31M
Enterprise value 9.49M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)N/A
Enterprise value/revenue 2.80
Enterprise value/EBITDA -0.47

Trading information

Stock price history

Beta (5Y monthly) 1.00
52-week change 3-95.68%
S&P500 52-week change 328.30%
52-week high 3650.00
52-week low 30.00
50-day moving average 322.32
200-day moving average 3117.19

Share statistics

Avg vol (3-month) 319.47k
Avg vol (10-day) 386.58k
Shares outstanding 543.85M
Implied shares outstanding 646.54M
Float 82.53M
% held by insiders 18.17%
% held by institutions 11.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1000
Last split date 302 Nov 2023

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,008.65%

Management effectiveness

Return on assets (ttm)-66.72%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.39M
Revenue per share (ttm)1.15
Quarterly revenue growth (yoy)-66.30%
Gross profit (ttm)N/A
EBITDA -14.69M
Net income avi to common (ttm)-20.82M
Diluted EPS (ttm)-3.68
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)239.82k
Total cash per share (mrq)0.05
Total debt (mrq)9.75M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.19
Book value per share (mrq)-2.21

Cash flow statement

Operating cash flow (ttm)-11.99M
Levered free cash flow (ttm)-5.55M